High-density lipoprotein cholesterol and systemic arterial hypertension are associated with hepatic necroinflammatory activity in patients with chronic hepatitis C
GHDPE Souza, LD Silva, DA Vieira… - Arquivos de …, 2023 - SciELO Brasil
Background: Approximately 71 million people are chronically infected with hepatitis C virus
(HCV) worldwide. A significant number of these individuals will develop liver cirrhosis and/or …
(HCV) worldwide. A significant number of these individuals will develop liver cirrhosis and/or …
[HTML][HTML] Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus
WF Hsu, HC Lai, SH Chen, WP Su… - American Journal of …, 2024 - ncbi.nlm.nih.gov
The impact of metabolic dysfunction or metabolic dysfunction-associated fatty liver disease
(MAFLD) on liver-related events (LREs) in patients with chronic hepatitis C (CHC) who had …
(MAFLD) on liver-related events (LREs) in patients with chronic hepatitis C (CHC) who had …
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan
CW Chang, WF Hsu, KC Tseng, CY Chen… - Digestive Diseases and …, 2024 - Springer
Abstract Background Chronic hepatitis C (CHC) increases the risk of liver cirrhosis (LC) and
hepatocellular carcinoma (HCC). This nationwide cohort study assessed the effectiveness of …
hepatocellular carcinoma (HCC). This nationwide cohort study assessed the effectiveness of …
Infection Risk in Patients with Biopsy-Proven Fatty Liver Disease: A Cohort Study
A Hamid, HT Aftab, S Mir - Link Medical Journal of Health and …, 2023 - linkmjhcr.com
Introduction: Nonalcoholic fatty liver disease (NAFLD). is increasingly becoming one of the
most common complex disorders worldwide and is related to higher morbidity because of its …
most common complex disorders worldwide and is related to higher morbidity because of its …